Company: SXTPW
Filing Date: 2025-08-15
Form Type: PRE 14A
Source: 0001213900-25-077435
Chunk: 39

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-15
Form: PRE 14A
Chunk 39
---
.

<div align='center'>20

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</div>

The following table sets forth information with
respect to the beneficial ownership of our common stock, our only outstanding class of voting stock, known by us as of the Record Date,
by:

| ● | each person or entity known by us to be the beneficial owner of more than 5% of our common stock; |
| ● | each of our directors;                                                                            |
| ● | each of our executive officers; and                                                               |
| ● | all of our directors and executive officers as a group.                                           |

Beneficial ownership is determined in accordance
with the rules of the SEC and, thus, represents voting or investment power with respect to our securities as of the Record Date. In computing
the number and percentage of shares beneficially owned by a person, shares that may be acquired by such person within 60 days of the Record
Date are counted as outstanding, while these shares are not counted as outstanding for computing the percentage ownership of any other
person. Except as otherwise indicated, the persons listed below have sole voting and investment power with respect to all shares of our
common stock owned by them, except to the extent such power may be shared with a spouse. Unless otherwise noted, the address of each person
below is c/o 60 Degrees Pharmaceuticals, Inc., 1025 Connecticut Avenue NW Suite 1000, Washington, D.C. 20036.

| Officers                                               
 and Directors                                          |     | Title                                |     | Number                       
 of Shares Beneficially Owned |        |    |     | Percent  
 of Class |      |   |
| Geoffrey                                               
 Dow                                                    |     | President,                           
 Chief Executive Officer and Director |     |                              | 37,766 | -2 |     |          |    * | % |
| Tyrone                                                 
 Miller                                                 |     | Chief                                
 Financial Officer                    |     |                              |  9,074 | -3 |     |          |    * |   |
| Kristen                                                
 Landon                                                 |     | Chief                                
 Commercial Officer                   |     |                              |  5,374 | -4 |     |          |    * |   |
| Charles                                                
 Allen                                                  |     | Director                             |     |                              |    518 | -5 |     |          |    * |   |
| Cheryl                                                 
 Xu                                                     |     | Director                             |     |                              | 16,100 | -6 |     |